Retina medicines

Retina clinics inject high-value biologics on a fixed schedule, and every vial must arrive cold and on the day of the clinic. That is exactly the kind of supply we are built for.

We supply anti-VEGF intravitreal injections used for wet age-related macular degeneration, diabetic macular oedema and retinal vein occlusion, along with related retina-clinic medicines, in innovator brands and approved biosimilars.

Retina practices usually order around injection days. We schedule cold-chain deliveries to match, so clinics hold less stock in their own refrigerators and waste fewer vials.

What we supply in retina

  • Anti-VEGF injections

    Ranibizumab, aflibercept, brolucizumab, faricimab and biosimilars.

  • Intravitreal implants & steroids

    Steroid implants and injections for macular oedema.

Commonly requested retina molecules

A reference list, not a live stock list. Most molecules are available in more than one brand — add what you need and our team confirms stock, brand options and rate.

Molecule Class Typical storage Action
Ranibizumab Anti-VEGF intravitreal injection 2–8 °C
Aflibercept Anti-VEGF intravitreal injection 2–8 °C
Brolucizumab Anti-VEGF intravitreal injection 2–8 °C
Faricimab Anti-VEGF / Ang-2 intravitreal injection 2–8 °C
Dexamethasone intravitreal implant Intravitreal corticosteroid Room temp.
Triamcinolone (intravitreal) Intravitreal corticosteroid Room temp.

Storage shown is typical for the molecule; always follow the product label. Don’t see a product? and we will check.

Retina questions

Do you supply biosimilar ranibizumab?

Yes, alongside the innovator brands. Tell us your clinic schedule and we will plan cold-chain delivery for each injection day.

Other therapy areas

Send us your requirement the way you already work

Most hospitals and chemists send a list on WhatsApp. You can also build one on this site, call, or email. We confirm availability, brand options and rates, usually the same working day.